Tylenol — Autism & ADHD Claims
The Preemption Fight — What It Means for Your Family
The cases are active again after the July 13, 2026 appeals ruling. What you can know today, in two minutes, is whether your family qualifies.
ACTIVE — NO SETTLEMENT. ~550 cases revived July 13, 2026 · returned to the federal trial court · new claims still reviewed.
Did you take Tylenol — or store-brand acetaminophen — while pregnant?
Yes — Check My Family’s Claimtakes 2 minutes I think so / not sureFree · confidential · no documents needed · answering doesn’t commit you to anything
Prefer to talk it through? (888) 348-2735 — free and confidential.
Stefanie A. Murphy & Matthew T. Marin
Partners
You’ll get a straight answer even if it’s “you don’t qualify.” Everything you share is confidential — even if you never hire us. No fee unless there is a recovery; costs are advanced and reimbursed only out of a recovery. If you do qualify, our Tylenol litigation team requests the medical and pharmacy records — you don’t chase them.
No court has found that Tylenol causes autism or ADHD, and no settlement has been reached. The question now before the courts is whether the science gets heard.
Litigation status — updated October 5, 2026: On July 13, 2026, the U.S. Court of Appeals for the Second Circuit vacated the judgments that had dismissed roughly 550 acetaminophen autism/ADHD cases and remanded them to the federal trial court in New York (Rutledge v. Walgreen Co.; Phippen v. Walgreen Co., Nos. 24-916(L), 24-2594 (2d Cir.); full opinion issued July 17, 2026). The court held the trial court “exceeded its discretion” in excluding three of the plaintiffs’ five expert witnesses — Drs. Baccarelli, Hollander, and Pearson — while upholding the exclusion of two others, and rejected the manufacturers’ federal-preemption defense. Kenvue, Tylenol’s maker, said on July 13 that it is “exploring all options regarding this decision.” On September 10, 2026, the defendants petitioned the Second Circuit for rehearing. As of October 4, 2026, no ruling on that petition has been reported. Unless rehearing is granted, the cases proceed in the trial court. The appeals court decided evidence and preemption questions only — no court has decided whether acetaminophen causes autism or ADHD, there is no trial date, and there is no settlement.
Case Update — July 17, 2026: On July 13, 2026 the U.S. Court of Appeals for the Second Circuit revived roughly 550 acetaminophen (Tylenol) autism and ADHD cases, reinstating three of the plaintiffs’ expert witnesses and rejecting the manufacturers’ federal preemption defense. The court expressly did not decide whether Tylenol causes autism or ADHD. There is no settlement, and no payout has been ordered.
Some families with pregnancies after early 2020 were told their Tylenol claim would be “preempted” by federal law and turned away. On July 13, 2026 the appeals court rejected that preemption defense — holding these failure-to-warn claims can proceed, and drawing no cutoff date. The reason those families were set aside may no longer apply.
Free case review: call (888) 348-2735 or request a free, confidential claim evaluation — available 24/7.
Key Takeaways
- A 2020 federal law (the CARES Act) reorganized how over-the-counter drug labels are regulated.
- Some firms worried that change “preempted” claims for pregnancies after early 2020 and declined them.
- On July 13, 2026 the appeals court rejected the preemption defense — with no before/after-2020 distinction.
- In plain terms: being told your pregnancy was “too recent” is no longer a reason to assume you don’t qualify.
- This is general information, not case-specific legal advice — a fresh review is the way to know.
Start with our complete overview: Tylenol autism lawsuit — full 2026 guide.
Related Tylenol lawsuit coverage: What the July 2026 ruling actually decided, Was the Tylenol lawsuit dismissed?, Tylenol for fever vs. pain in pregnancy
What “preemption” meant here
Preemption is the idea that federal law can override a state-law claim. For over-the-counter drugs like acetaminophen, the label is set by an FDA “monograph.” The argument some firms worried about went like this: because a 2020 federal law (the CARES Act) made those monographs “final,” a manufacturer supposedly could not add its own pregnancy warning — so claims for exposures after that change might be preempted. Rather than risk it, some intake teams simply declined pregnancies after early 2020.
Why that concern is much weaker now
On July 13, 2026 the appeals court rejected the preemption defense. It held that federal rules do not prohibit manufacturers from adding supplemental, specific pregnancy warnings, and it did so across the board — with no distinction between pregnancies before or after 2020. If a manufacturer could have added the warning, complying with both state and federal law was not impossible, so the claims are not preempted. The date-based screen those declines relied on lost its footing.
What this is — and is not
This is general information about how the litigation changed, not advice about your specific case. A defendant can still raise arguments on remand, and every case is different. But if you were turned away because your pregnancy was “too recent,” that is no longer a reason to assume the door is closed. Many qualifying cases may resolve for far less, and no amount can be promised.
If your pregnancy was during or after 2020
That timing is common in this litigation and, on its own, is not a disqualifier. If your child was later diagnosed with autism or ADHD, a free, confidential review can look at your history fresh. Request a free review or call (888) 348-2735.
Frequently asked questions
Is my Tylenol claim preempted if my pregnancy was after 2020?
The appeals court rejected the preemption defense in July 2026 with no date cutoff, so a post-2020 pregnancy is not, by itself, a reason to assume preemption. Your specific case should still be reviewed.
What does the CARES Act have to do with my claim?
The CARES Act (2020) changed how over-the-counter drug labels are regulated. Some firms thought that change preempted newer claims. The appeals court’s ruling undercut that theory.
I was told my case was ‘too recent.’ Is that still true?
It is much weaker now. “Too recent” was usually shorthand for the preemption concern the court just rejected. It is worth having your case re-reviewed.
Does it matter that I took Tylenol for a COVID fever?
That goes to causation, not eligibility — whether a fever or the medication explains an outcome is a question for the case. It does not automatically disqualify you.
Is there a settlement for these cases?
No. There is no settlement, and dollar figures online are estimates. Many qualifying cases may resolve for far less, and no amount can be promised.
Talk to the Tylenol litigation team. Request a free, confidential case review or call (888) 348-2735. There is no fee unless there is a recovery. The firm advances court costs and litigation expenses, and those expenses are repaid from the recovery. You are not responsible for court costs or litigation expenses if there is no recovery, unless a court directs otherwise. The attorney’s fee is a percentage of the gross recovery, calculated before expenses are deducted.
Attorney Advertising. Marin & Murphy is licensed in Rhode Island, Massachusetts, Connecticut, and South Carolina; matters in other states are handled with local co-counsel. This page is general information about the acetaminophen (Tylenol) autism and ADHD litigation, not legal advice, and does not create an attorney-client relationship. Prior results do not guarantee a similar outcome.
Tylenol (acetaminophen) autism and ADHD claims are handled together with co-counsel, who carry principal responsibility for these matters; Marin & Murphy maintains joint responsibility. Whether a claim is accepted is determined after review, and no attorney-client relationship is created until a written engagement agreement is signed.